Revision of the USP Chapter on Spectroscopic Methods

Recommendation
13-15 May 2025
Vienna, Austria
Practical Approaches for USP General Chapter <1058> Compliance in the QC Laboratory
In the USP Pharmacopeial Forum 40(1), a "Stimuli to the Revision Process" article states that the responsible working group of the USP has conducted a review of the existing general chapters on spectroscopic methods.
The goal of this review was to establish a uniform concept for all the spectroscopic methods and generate a common format. As a result, consistency in the overall approach and ease of use in the future should also be enabled for the user.
The general chapters smaller than <1.000> show how to correctly use the methods ("suitability for use"), whereas the general chapters greater than <1.000> additionally provide so-called "best practices". Those chapters also include provisions on instrument qualification and on validation of spectroscopic methods.
That's why some of these General USP Chapters have been once again published in this issue of the Pharmacopeial Forum:
<852> Atomic Absorption Spectroscopy
<853> Fluorescence Spectroscopy
<854> Mid-Infrared Spectroscopy
<857> Ultraviolet-Visible Spectroscopy
and as supplement to these chapters:
<1852> Atomic Absorption Spectroscopy - Theory and Practice
<1853> Fluorescence Spectroscopy - Theory and Practice
<1854> Mid-Infrared Spectroscopy - Theory and Practice
All these chapters are planned for the edition USP38/NF33 and will thus become effective in the coming year.
You will find more information on the USP Pharmacopeial Forum website.
PS: Dr Chris Burgess, member of this USP experts group, will present the new USP developments in spectroscopy during the ECA course "Analytical Instrument Qualification" from 19-21 May 2014 in Berlin, Germany.
Related GMP News
10.02.2025USP Announces Corrections to General Chapter <1132.1> on Residual Host Cell Protein Measurement
10.02.2025FDA Warning Letter: Focus on Quality Control of APIs and Excipients
29.01.2025Revision of USP <1032> Design and Development of Biological Assays
23.01.2025English Translation of Supplement II to the Japanese Pharmacopoeia (JP18) Published
23.01.2025How to keep Analytical Systems Current and Compliant
23.01.2025FDA 483s due to Deficiencies in the Stability Program: Evaluation of Fiscal Year 2024